Immorna Biotherapeutics, Inc a, clinical stage biotechnology company developing both self-replicating and conventional mRNA-based therapeutics and vaccines, has officially secured FDA's approval for its...
Serac Healthcare Limited, a clinical radiopharmaceutical company developing an innovative molecular imaging agent, has officially secured FDA's Fast Track Designation for its 99mTc-maraciclatide as...
